Wedbush Upgrades US Ecology (ECOL) to Neutral; Pending Acquisitions and Hudson River Project Substantially Reduce Downside Risk
Tweet Send to a FriendGet Alerts ECOL Hot Sheet
Price: $29.08 -0.38%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade ECOL Now!
Wedbush upgrades US Ecology (Nasdaq: ECOL) from Underperform to Neutral. PT increased from $13 to $14.50.
Wedbush analyst says, "With the commencement of Phase I of the General Electric (NYSE: GE) Hudson River project and its recently announced acquisitions, including Stablex Canada, we now believe that the risk-reward profile for the company has shifted to neutral from unfavorable as outlined in our downgrade on July 28. We expect the recovery process, including commercial and real estate development, to remain prolonged, and challenges remain."
To see all the upgrades/downgrades on shares of ECOL, visit our Analyst Ratings page.
Shares move out of the basement and are currently trading at $15.29, up $0.33 (+2.21%).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Wedbush analyst says, "With the commencement of Phase I of the General Electric (NYSE: GE) Hudson River project and its recently announced acquisitions, including Stablex Canada, we now believe that the risk-reward profile for the company has shifted to neutral from unfavorable as outlined in our downgrade on July 28. We expect the recovery process, including commercial and real estate development, to remain prolonged, and challenges remain."
To see all the upgrades/downgrades on shares of ECOL, visit our Analyst Ratings page.
Shares move out of the basement and are currently trading at $15.29, up $0.33 (+2.21%).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- Macquarie Upgrades American Tower (AMT) to Outperform
- Maxim Group Upgrades J. C. Penney (JCP) to Buy, Sees 50% Upside
Create E-mail Alert Related Categories
Upgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
